Act Capital Management, LLC Clearside Biomedical, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 2,197,480 shares of CLSD stock, worth $2.02 Million. This represents 3.43% of its overall portfolio holdings.
Number of Shares
2,197,480
Previous 2,288,200
3.96%
Holding current value
$2.02 Million
Previous $3.36 Million
26.19%
% of portfolio
3.43%
Previous 4.7%
Shares
6 transactions
Others Institutions Holding CLSD
# of Institutions
55Shares Held
12MCall Options Held
54.7KPut Options Held
50.7K-
Vanguard Group Inc Valley Forge, PA2.84MShares$2.61 Million0.0% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$1.78 Million0.04% of portfolio
-
Black Rock Inc. New York, NY798KShares$734,2860.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny745KShares$685,2970.0% of portfolio
-
Geode Capital Management, LLC Boston, MA731KShares$672,8750.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $55.4M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...